Blog dedicated to the continuous education in Gynecology and Endocrinology

 

OBESITY: MENSTRUAL AND REPRODUCTIVE IMPACT

powered by WordPress Multibox Plugin v1.3.5

Stress, Rank, and Obesity: Understanding the Reproductive Consequences of Obesity
Berga, Sarah

powered by WordPress Multibox Plugin v1.3.5

Endometrial factors and reproductive function in women with polycystic ovary syndrome Hirschberg, Angelica

powered by WordPress Multibox Plugin v1.3.5

Metabolic disorders in Polish Women over 60 years old and Serum Vitamin D and its Receptor Gene Polymorphism? PolSenior Study
Milewicz, Andrzej

powered by WordPress Multibox Plugin v1.3.5

Cellulite Pathophysiology
Bevilacqua, Maurizio

Post to Twitter Post to Facebook

Serum platelet-activating factor acetylhydrolase activity: Relationship with metabolic syndrome in women with history of gestational diabetes mellitus

DGYE-2010-0018.R1[487612 ]

Derbent, Aysel, carlioglu, ayse; Koca, Cemile; Gumus, Ilknur; Simavlı, Serap; Sevgili, Sema; Karakurt, Feridun; Turhan, Nilgün

Objective. The aim of this study was to evaluate plasma platelet-activating factor acetylhydrolase (PAF-AH) activity in euglycemic women with history of gestational diabetes (GDM), and to explore whether this activity is associated with metabolic syndrome (MS) in this group of women. Methods. more

Post to Twitter Post to Facebook

Association of plasma leptin levels and insulin resistance in diabetic women: a cross sectional analysis in an Iranian population with different results in men and women

DGYE-2009-0188.R1[487583] 6 PAG Original Paper
Abbasi, Mehrshad, Nakhjavani, Manouchehr; Esteghamati, Alireza; Tarafdari, Azam; Nikzamir, Abdolrahim; Ashraf, Haleh

The objective of this study was to assess the association of serum leptin levels with insulin resistance (IR), metabolic syndrome (MetS), lipid levels, and glucose control in an Iranian type 2 diabetic population. In this cross-sectional analysis, 132 type 2 diabetic patients (79 women) and 71 healthy non-diabetic and non-hypertensive individuals (40 women; as control subjects) were included. more

Post to Twitter Post to Facebook

CLINICAL AND THERAPEUTICAL ASPECTS OF PCOS

powered by WordPress Multibox Plugin v1.3.5

Insulin regulates both basal and stimulated gonadotropins secretion in PCOS patients: different effect of metformin, hypocaloric and low glucidic diet
Glinski L

powered by WordPress Multibox Plugin v1.3.5

Association between serum adipocyte factor and insulin resistance in PCOS
Huang W

powered by WordPress Multibox Plugin v1.3.5

Policystic ovary syndrome and benign breast disease: two aspects of the same dysmetabolic condition
Londero AP

powered by WordPress Multibox Plugin v1.3.5

Follicular function and metabolic assessment in obese women with polycystic ovary syndrome: Antimullerian hormone after insulin-sensitizing therapy
Ricciardi L

powered by WordPress Multibox Plugin v1.3.5

Metformin inhibits aromatase via an ERK-mediated pathway
Rice S

powered by WordPress Multibox Plugin v1.3.5

Autoimmunity and Polycystic Ovary Syndrome
Rinaldi E

powered by WordPress Multibox Plugin v1.3.5

Metabolic features and uterine artery color doppler analysis in polycistic ovary syndrome (PCOS) and control women
Signori C

powered by WordPress Multibox Plugin v1.3.5

Genetic predisposition of polycystic ovarian disease: Report of clusters within 10 large families; inclusion of novel signs and describing male PCOD
Talaee RZ

Post to Twitter Post to Facebook

Menstrual irregularity: a possible clinical marker of metabolic dysfunction in women with class iii obesity

Souza, Francisco de Assis Dias, Rogerio; Filho, Fernando; Fernandes, Cesar; Dias, Daniel DGYE-2009-0217.r1

Purpose: To evaluate whether menstrual irregularity in morbidly obese women is indicative of metabolic dysfunction. Patients and Methods: Fifty-seven women with morbid obesity were evaluated. They were divided into 2 groups: one comprising women without menstrual dysfunctions or hirsutism (Group 1), and another obese women showing menstrual dysfunction with or without hirsutism (Group 2). more

Post to Twitter Post to Facebook

© International Society of Gynecological Endocrinology - Privacy Policy